Authorized Generics Under Scrutiny By The FTC
With the debate over authorized generics heating up in recent months, this week's move by the Federal Trade Commission to determine whether the practice violates anticompetitive guidelines could have wide-ranging effects...To view the full article, register now.
Already a subscriber? Click here to view full article